Back to search

Oxford Gene Technology (Operations) Ltd

03845432

active
Private Limited Company
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Negative net worth (-10)
  • Loss before tax (-10)
  • Current liabilities exceed current assets (-10)
  • Going concern doubt noted in accounts (-10)

Details

UNIT 5 OXFORD TECHNOLOGY PARK, KIDLINGTON, OX5 1GN
Incorporated 21/09/1999

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Anthony John Lenhardt

secretary · Since 18/05/2006

ACCOUNTANT

BRITISH · Age 65

Also on 4 other boards

Mr Gregory Alun Williams

director · Since 30/01/2019

CFO

BRITISH · ENGLAND · Age 45

Also on 6 other boards

Mr Adrian Brian Smith

director · Since 28/04/2022

CEO

BRITISH · ENGLAND · Age 54

Also on 4 other boards

Mr Kenji Iwakabe

director · Since 07/05/2025

DIRECTOR

JAPANESE · JAPAN · Age 51

Persons with Significant Control

Oxford Gene Technology Ip Limited

75–100% shares
75–100% votes
Appoint directors

Iat Building, Begbroke Science Park, Begbroke Hill, Begbroke, OX5 1PF

Reg: 03845467 · England · Limited Company

Notified 06/04/2016

Former PSCs

Prof Sir Edwin Mellor Southern

Ceased 06/04/2016

Charges0 outstanding

Charge
satisfied

SILICON VALLEY BANK

Created 28/02/2014Registered 11/03/2014Satisfied 28/02/2017

CompanyRankvs 1675+ SIC 72110 peers
41

Financial strength0th percentile among SIC peers · 0/25
Employees99th percentile among SIC peers · 15/15
LiquidityCurrent ratio 0.59× · 6/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
How is this score calculated?
Financial strength0/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity6/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going co

Key FinancialsYear ending 31/03/2025

Turnover

£10.3M

Annual revenue

Net Worth

-£26.3M

Balance sheet strength

Cash

£4.2M

Cash in the bank

Profit Before Tax

-£101k

Bottom line earnings

Net Current Assets

-£28.0M

Working capital

Current Assets

£39.9M

Current Liabilities

£67.8M

Fixed Assets

£3.1M

Debtors

£34.2M

Cost of Sales

£5.8M

Gross Profit

£4.5M

Admin Expenses

£5.6M

Operating Profit

-£561k

Profit After Tax

-£353k

58avg. employees+10

People Costs

Wages & salaries£3.4M
NI contributions£434k

Balance Sheet

Assets less current liabilities-£24.9M
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearCurrent RatioImplied Profit
20250.59-£353k
20240.56+£758k
20230.54

Derived from filed accounts. Not audited figures.